Global Artificial Tissue Heart Valve Market Research Report 2021

1 Artificial Tissue Heart Valve Market Overview

• 1.1 Product Overview and Scope of Artificial Tissue Heart Valve
• 1.2 Artificial Tissue Heart Valve Segment by Type
  • 1.2.1 Global Artificial Tissue Heart Valve Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Transcatheter Heart Valve
  • 1.2.3 Surgical Heart Valve
• 1.3 Artificial Tissue Heart Valve Segment by Application
  • 1.3.1 Artificial Tissue Heart Valve Sales Comparison by Application: (2021-2027)
  • 1.3.2 Aortic Stenosis
  • 1.3.3 Aortic Regurgitation
  • 1.3.4 Others
• 1.4 Global Artificial Tissue Heart Valve Market Size Estimates and Forecasts
  • 1.4.1 Global Artificial Tissue Heart Valve Revenue 2016-2027
  • 1.4.2 Global Artificial Tissue Heart Valve Sales 2016-2027
  • 1.4.3 Artificial Tissue Heart Valve Market Size by Region: 2016 Versus 2021 Versus 2027

2 Artificial Tissue Heart Valve Market Competition by Manufacturers

• 2.1 Global Artificial Tissue Heart Valve Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Artificial Tissue Heart Valve Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Artificial Tissue Heart Valve Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Artificial Tissue Heart Valve Manufacturing Sites, Area Served, Product Type
• 2.5 Artificial Tissue Heart Valve Market Competitive Situation and Trends
  • 2.5.1 Artificial Tissue Heart Valve Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Artificial Tissue Heart Valve Players Market Share by Revenue
  • 2.5.3 Global Artificial Tissue Heart Valve Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artificial Tissue Heart Valve Retrospective Market Scenario by Region

• 3.1 Global Artificial Tissue Heart Valve Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Artificial Tissue Heart Valve Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Artificial Tissue Heart Valve Market Facts & Figures by Country
  • 3.3.1 North America Artificial Tissue Heart Valve Sales by Country
  • 3.3.2 North America Artificial Tissue Heart Valve Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Artificial Tissue Heart Valve Market Facts & Figures by Country
  • 3.4.1 Europe Artificial Tissue Heart Valve Sales by Country
  • 3.4.2 Europe Artificial Tissue Heart Valve Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Artificial Tissue Heart Valve Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Artificial Tissue Heart Valve Sales by Region
  • 3.5.2 Asia Pacific Artificial Tissue Heart Valve Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Artificial Tissue Heart Valve Market Facts & Figures by Country
  • 3.6.1 Latin America Artificial Tissue Heart Valve Sales by Country
  • 3.6.2 Latin America Artificial Tissue Heart Valve Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Artificial Tissue Heart Valve Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Artificial Tissue Heart Valve Sales by Country
  • 3.7.2 Middle East and Africa Artificial Tissue Heart Valve Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Artificial Tissue Heart Valve Historic Market Analysis by Type

• 4.1 Global Artificial Tissue Heart Valve Sales Market Share by Type (2016-2021)
• 4.2 Global Artificial Tissue Heart Valve Revenue Market Share by Type (2016-2021)
• 4.3 Global Artificial Tissue Heart Valve Price by Type (2016-2021)

5 Global Artificial Tissue Heart Valve Historic Market Analysis by Application

• 5.1 Global Artificial Tissue Heart Valve Sales Market Share by Application (2016-2021)
• 5.2 Global Artificial Tissue Heart Valve Revenue Market Share by Application (2016-2021)
• 5.3 Global Artificial Tissue Heart Valve Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Edwards Lifesciences
  • 6.1.1 Edwards Lifesciences Corporation Information
  • 6.1.2 Edwards Lifesciences Description and Business Overview
  • 6.1.3 Edwards Lifesciences Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Edwards Lifesciences Product Portfolio
  • 6.1.5 Edwards Lifesciences Recent Developments/Updates
• 6.2 Medtronic
  • 6.2.1 Medtronic Corporation Information
  • 6.2.2 Medtronic Description and Business Overview
  • 6.2.3 Medtronic Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Medtronic Product Portfolio
  • 6.2.5 Medtronic Recent Developments/Updates
• 6.3 Abbott
  • 6.3.1 Abbott Corporation Information
  • 6.3.2 Abbott Description and Business Overview
  • 6.3.3 Abbott Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Abbott Product Portfolio
  • 6.3.5 Abbott Recent Developments/Updates
• 6.4 Livanova
  • 6.4.1 Livanova Corporation Information
  • 6.4.2 Livanova Description and Business Overview
  • 6.4.3 Livanova Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Livanova Product Portfolio
  • 6.4.5 Livanova Recent Developments/Updates
• 6.5 Boston Scientific
  • 6.5.1 Boston Scientific Corporation Information
  • 6.5.2 Boston Scientific Description and Business Overview
  • 6.5.3 Boston Scientific Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Boston Scientific Product Portfolio
  • 6.5.5 Boston Scientific Recent Developments/Updates
• 6.6 Cryolife
  • 6.6.1 Cryolife Corporation Information
  • 6.6.2 Cryolife Description and Business Overview
  • 6.6.3 Cryolife Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Cryolife Product Portfolio
  • 6.6.5 Cryolife Recent Developments/Updates
• 6.7 Suzhou Jiecheng Medical Technology Co., Ltd.
  • 6.6.1 Suzhou Jiecheng Medical Technology Co., Ltd. Corporation Information
  • 6.6.2 Suzhou Jiecheng Medical Technology Co., Ltd. Description and Business Overview
  • 6.6.3 Suzhou Jiecheng Medical Technology Co., Ltd. Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Suzhou Jiecheng Medical Technology Co., Ltd. Product Portfolio
  • 6.7.5 Suzhou Jiecheng Medical Technology Co., Ltd. Recent Developments/Updates
• 6.8 Labcor Laboratórios Ltda
  • 6.8.1 Labcor Laboratórios Ltda Corporation Information
  • 6.8.2 Labcor Laboratórios Ltda Description and Business Overview
  • 6.8.3 Labcor Laboratórios Ltda Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Labcor Laboratórios Ltda Product Portfolio
  • 6.8.5 Labcor Laboratórios Ltda Recent Developments/Updates
• 6.9 Braile Biomédica
  • 6.9.1 Braile Biomédica Corporation Information
  • 6.9.2 Braile Biomédica Description and Business Overview
  • 6.9.3 Braile Biomédica Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Braile Biomédica Product Portfolio
  • 6.9.5 Braile Biomédica Recent Developments/Updates
• 6.10 MicroPort Scientific Corporation
  • 6.10.1 MicroPort Scientific Corporation Corporation Information
  • 6.10.2 MicroPort Scientific Corporation Description and Business Overview
  • 6.10.3 MicroPort Scientific Corporation Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 MicroPort Scientific Corporation Product Portfolio
  • 6.10.5 MicroPort Scientific Corporation Recent Developments/Updates
• 6.11 Beijing Balance Medical Technology Co., Ltd.
  • 6.11.1 Beijing Balance Medical Technology Co., Ltd. Corporation Information
  • 6.11.2 Beijing Balance Medical Technology Co., Ltd. Artificial Tissue Heart Valve Description and Business Overview
  • 6.11.3 Beijing Balance Medical Technology Co., Ltd. Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Beijing Balance Medical Technology Co., Ltd. Product Portfolio
  • 6.11.5 Beijing Balance Medical Technology Co., Ltd. Recent Developments/Updates
• 6.12 Myval
  • 6.12.1 Myval Corporation Information
  • 6.12.2 Myval Artificial Tissue Heart Valve Description and Business Overview
  • 6.12.3 Myval Artificial Tissue Heart Valve Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Myval Product Portfolio
  • 6.12.5 Myval Recent Developments/Updates

7 Artificial Tissue Heart Valve Manufacturing Cost Analysis

• 7.1 Artificial Tissue Heart Valve Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Artificial Tissue Heart Valve
• 7.4 Artificial Tissue Heart Valve Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Artificial Tissue Heart Valve Distributors List
• 8.3 Artificial Tissue Heart Valve Customers

9 Artificial Tissue Heart Valve Market Dynamics

• 9.1 Artificial Tissue Heart Valve Industry Trends
• 9.2 Artificial Tissue Heart Valve Growth Drivers
• 9.3 Artificial Tissue Heart Valve Market Challenges
• 9.4 Artificial Tissue Heart Valve Market Restraints

10 Global Market Forecast

• 10.1 Artificial Tissue Heart Valve Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Artificial Tissue Heart Valve by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Artificial Tissue Heart Valve by Type (2022-2027)
• 10.2 Artificial Tissue Heart Valve Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Artificial Tissue Heart Valve by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Artificial Tissue Heart Valve by Application (2022-2027)
• 10.3 Artificial Tissue Heart Valve Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Artificial Tissue Heart Valve by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Artificial Tissue Heart Valve by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List